HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2‐dependent manner
暂无分享,去创建一个
K. Sawanyawisuth | C. Pairojkul | S. Wongkham | K. Vaeteewoottacharn | Guojun Sheng | G. Sashida | S. Waraasawapati | Jie Bai | Mariko Morii | Sho Kubota | Takako Yokomizo-Nakano | Supannika Sorin | Sofiane Hamidi
[1] Guojun Sheng. Defining epithelial-mesenchymal transitions in animal development. , 2021, Development.
[2] G. Gores,et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.
[3] Raymond B. Runyan,et al. Guidelines and definitions for research on epithelial–mesenchymal transition , 2020, Nature Reviews Molecular Cell Biology.
[4] B. Teh,et al. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient , 2020, Human Cell.
[5] T. Efferth,et al. Chemoresistance and chemosensitization in cholangiocarcinoma. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[6] Bin Tean Teh,et al. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. , 2017, Cancer discovery.
[7] V. Paradis,et al. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. , 2017, Journal of hepatology.
[8] R. Reeves. High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells. , 2015, DNA repair.
[9] A. Zhu. Future directions in the treatment of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.
[10] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[11] Nataliya Razumilava,et al. Cholangiocarcinoma , 2014, The Lancet.
[12] H. Saya,et al. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis , 2014, Tumor Biology.
[13] Sharon Nofech-Mozes,et al. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. , 2014, Archives of pathology & laboratory medicine.
[14] G. Gores,et al. Pathogenesis, diagnosis, and management of cholangiocarcinoma. , 2013, Gastroenterology.
[15] H. Fuchs,et al. High Mobility Group N Proteins Modulate the Fidelity of the Cellular Transcriptional Profile in a Tissue- and Variant-specific Manner* , 2013, The Journal of Biological Chemistry.
[16] Michael Bustin,et al. Effects of HMGN variants on the cellular transcription profile , 2011, Nucleic acids research.
[17] Dong-sheng Wang,et al. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma , 2010, Journal of experimental & clinical cancer research : CR.
[18] H. Ford,et al. Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.
[19] M. Bustin. High mobility group proteins. , 2010, Biochimica et biophysica acta.
[20] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[21] M. Bustin,et al. The Nucleosome Binding Protein HMGN3 Modulates the Transcription Profile of Pancreatic β Cells and Affects Insulin Secretion , 2009, Molecular and Cellular Biology.
[22] Hyeon Je Cho,et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[23] T. Rikiyama,et al. Bile acids repress E‐cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma , 2008, Cancer science.
[24] C. Pairojkul,et al. Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.
[25] M. Bustin,et al. HMG chromosomal proteins in development and disease. , 2007, Trends in cell biology.
[26] M. Miwa,et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). , 2005, World journal of gastroenterology.
[27] M. Bustin,et al. Chromosomal Proteins HMGN3a and HMGN3b Regulate the Expression of Glycine Transporter 1 , 2004, Molecular and Cellular Biology.
[28] D. Stolz,et al. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT , 2004, Transplantation.
[29] Erik Schrumpf,et al. Diagnosis and treatment of cholangiocarcinoma , 2004, Current gastroenterology reports.
[30] E. Ballestar,et al. Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex , 2004, Molecular and Cellular Biology.
[31] Avri Ben-Ze'ev,et al. Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.
[32] M. Fraga,et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.
[33] M. Bustin,et al. HMGN3a and HMGN3b, Two Protein Isoforms with a Tissue-specific Expression Pattern, Expand the Cellular Repertoire of Nucleosome-binding Proteins* , 2001, The Journal of Biological Chemistry.
[34] M. Bustin. Chromatin unfolding and activation by HMGN(*) chromosomal proteins. , 2001, Trends in biochemical sciences.